Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis.

Abstract

A six week, double-blind, randomized, parallel group, multicentre study was conducted in 85 patients with osteoarthritis of the knee and hip to compare the efficacy, tolerability, and safety of Flurbiprofen-SR 200 mg with Diclofenac Sodium-SR 100 mg. Between group comparisons, based on change scores from baseline, we detected no significant differences between the two drugs with respect to efficacy for the majority of outcome measures. There was no significant difference between the groups in the proportion of patients experiencing at least one adverse medical event or in terminations from treatment. We conclude that Flurbiprofen-SR 200 mg is similar in efficacy, tolerability, and safety to Diclofenac Sodium-SR in this trial.

• Authors: N Bellamy, W G Bensen, P M Ford, S H Huang, J Y Lang
• Journal: Clinical and investigative medicine. Medecine clinique et experimentale (Clin Invest Med) Vol. 15 Issue 5 Pg. 427-33 (Oct 1992) ISSN: 0147-958X [Print] Canada
• PMID: 1458715 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Diclofenac
• Flurbiprofen

Topics

• Adolescent
• Adult
• Aged
• Diclofenac (adverse effects, therapeutic use)
• Double-Blind Method
• Flurbiprofen (adverse effects, therapeutic use)
• Humans
• Middle Aged
• Osteoarthritis (drug therapy)
• Osteoarthritis, Hip (drug therapy)
• Patient Compliance